Nu Skin Enterprises, Inc. NUS
Set alert
4.65 USD -0.04 -0.85%
At close · Oct 30
4.65 0.00 0.00%
After hours · Oct 30, 4:01 PM ET
4.63 Day range 4.80
4.53 52-week range 11.54
- YTD
- -51.66%
- 1 year
- -56.21%
- Open
- 4.71
- Prev close
- 4.69
- Mkt cap
- 226.35M
- Vol
- 351.49K
- Avg vol
- 526.88K
- EPS
- -4.51
- P/E
- 0.00
- Div yield
- 3.64%
More statistics
- Low
- 4.63
- High
- 4.80
- Forward P/E
- 6.47
- Beta
- 1.13
- Short ratio
- 1.83
- Inst. own
- 81.02%
- Dividend
- 0.24
- Ex-div date
- Nov 28, 2024
- Earnings
- Feb 12, 2025
- 50-d avg
- 6.96
- 200-d avg
- 9.95
- 1y target
- 6.92
2Y chart
Events in this range
- Nov 7, 2024Earnings: 0.17; estimate 0.2; surprise -15%
- Nov 29, 2024Dividend: 0.06
- Dec 20, 2024Rating: DA Davidson · Neutral → Neutral
- Feb 12, 2025Earnings: —; estimate 0.21; surprise —%
- Feb 24, 2025Dividend: 0.06
- May 30, 2025Dividend: 0.06
- Aug 29, 2025Dividend: 0.06
- Nov 28, 2025Dividend: 0.06
- Feb 27, 2026Dividend: 0.06
- May 29, 2026Dividend: 0.06
- Aug 28, 2026Dividend: 0.06
Signals (78)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 26, 2026 | 5 days ago |
| MACD: Sell Signal | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 5, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 17, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 2, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 27, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 2 months ago |
| RSI: Oversold | Jun 25, 2026 | 4 months ago |
| RSI: Oversold | Jun 15, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 10, 2026 | 4 months ago |
| RSI: Oversold | May 29, 2026 | 5 months ago |
| RSI: Oversold | May 13, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 17, 2026 | 7 months ago |
| RSI: Oversold | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Feb 13, 2026 | 8 months ago |
| RSI: Oversold | Feb 13, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Jan 29, 2026 | 9 months ago |
| SMA: Bearish | Jan 28, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 28, 2026 | 9 months ago |
| RSI: Overbought | Jan 15, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| SMA: Bullish | Jan 6, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 24, 2025 | 10 months ago |
| SMA: Bearish | Dec 22, 2025 | 10 months ago |
| SMA: Bullish | Dec 19, 2025 | 10 months ago |
| SMA: Bearish | Dec 18, 2025 | 10 months ago |
| SMA: Bullish | Dec 11, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 21, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 7, 2025 | 11 months ago |
| RSI: Oversold | Nov 7, 2025 | 11 months ago |
| MACD: Buy Signal | Oct 24, 2025 | 1 year ago |
| SMA: Bearish | Oct 7, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 3, 2025 | 1 year ago |
| RSI: Overbought | Aug 22, 2025 | 1 year ago |
| RSI: Overbought | Aug 12, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 11, 2025 | 1 year ago |
| SMA: Bullish | Aug 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 7, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Aug 1, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 25, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 23, 2025 | 1 year ago |
| RSI: Overbought | Jul 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 15, 2025 | 1 year ago |
| RSI: Overbought | Jul 8, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 1, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 11, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 10, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 9, 2025 | 1 year ago |
| RSI: Overbought | May 29, 2025 | 1 year ago |
| SMA: Bullish | May 9, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 28, 2025 | 1 year ago |
| RSI: Oversold | Apr 17, 2025 | 1 year ago |
| RSI: Oversold | Apr 8, 2025 | 1 year ago |
| SMA: Bearish | Mar 28, 2025 | 1 year ago |
| SMA: Bullish | Mar 27, 2025 | 1 year ago |
| SMA: Bearish | Mar 25, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 13, 2025 | 1 year ago |
| SMA: Bullish | Feb 14, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 14, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 31, 2025 | 1 year ago |
| SMA: Bearish | Jan 22, 2025 | 1 year ago |
| SMA: Bullish | Jan 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 16, 2025 | 1 year ago |
| RSI: Overbought | Nov 27, 2024 | 1 year ago |
| RSI: Overbought | Nov 25, 2024 | 1 year ago |
Key statistics
- Market cap
- 334.56M
- Enterprise value
- 614.80M
- Trailing P/E
- 0.00
- Forward P/E
- 6.47
- PEG ratio
- 0.00
- Price / sales
- 0.19
- Price / book
- 0.47
- EPS (TTM)
- -2.09
- Beta
- 1.13
- Dividend yield
- 3.64%
- Payout ratio
- 917.65%
- Profit margin
- -5.81%
- Revenue (TTM)
- 1.78B
- Revenue growth
- -13.80%
- Free cash flow
- 131.05M
- Total cash
- 244.09M
- Total debt
- 530.80M
- Return on equity
- -13.50%
- Shares outstanding
- 49.71M
- Short % of float
- 4.67%
- 50-day average
- 6.96
- 200-day average
- 9.95
Analyst view
Consensus: hold
Hold
Price target (mean) 6.92 +48.7% upside
Now 4.65
- Target (low)
- 6.75
- Target (mean)
- 6.92
- Target (high)
- 7.00
Ratings (0m) 3 0 buy · 3 hold · 0 sell
- Strong buy0
- Buy0
- Hold3
- Sell0
- Strong sell0
Next earnings
Feb 12, 2025
Expected Feb 12, 2025. Consensus EPS estimate 0.24582.
Financials — quick view
NUS Revenue — quarterly 320.11M
NUS Net income — quarterly -249.80M
NUS EPS — quarterly -5.14
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 12, 2025 | Dec 1, 2024 | 0.21 | — | — | — |
| Nov 7, 2024 | Sep 1, 2024 | 0.20 | 0.17 | -0.03 | -15.00% |
| Aug 8, 2024 | Jun 1, 2024 | 0.18 | 0.21 | +0.03 | +16.67% |
| May 8, 2024 | Mar 1, 2024 | 0.05 | 0.09 | +0.04 | +80.00% |
| Feb 14, 2024 | Dec 1, 2023 | 0.29 | 0.37 | +0.08 | +27.59% |
| Nov 1, 2023 | Sep 1, 2023 | 0.64 | 0.56 | -0.08 | -12.50% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | DA Davidson | main | Neutral | Neutral |
| Oct 22, 2024 | Citigroup | main | Neutral | Neutral |
| Aug 12, 2024 | DA Davidson | main | Neutral | Neutral |
| Aug 9, 2024 | Citigroup | main | Neutral | Neutral |
| May 9, 2024 | DA Davidson | main | Neutral | Neutral |
| Jan 5, 2024 | DA Davidson | main | Neutral | Neutral |
About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Country
- United States
- Website
- nuskin.com
News
- Nu Skin Enterprises to Announce Third Quarter 2026 Financial Results
- Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
- Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
- STMicroelectronics-NUS Lab Strengthens Low-Power Edge AI Push
- STMicroelectronics and NUS launch Corporate Lab to power the future of Edge AI in Singapore
- Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26
- Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y
- Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript
- Nu Skin Enterprises Q2 Earnings Call Highlights
- Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates
Your note
Sign in to keep a note on NUS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BATTLE EMMA S. | Director | Stock Award(Grant) | Jun 6, 2024 | 19,223 |
| CAMPBELL DANIEL W | Director | Stock Award(Grant) | Jun 6, 2024 | 117,030 |
| CLARK CHAYCE DAVID | General Counsel | Stock Award(Grant) | Feb 26, 2024 | 158,175 |
| LIPMAN ANDREW D | Director | Sale | May 27, 2024 | 23,225 |
| NATHANSON LAURA | Director | Stock Award(Grant) | Jun 6, 2024 | 21,630 |
| SHEN ZHEQING | Director | Stock Award(Grant) | Jun 6, 2024 | 33,195 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 10.27% | 5,104,656 | 34.35M | Sep 29, 2024 |
| Blackrock Inc. | 9.24% | 4,592,141 | 30.91M | Sep 29, 2024 |
| Shaw D.E. & Co., Inc. | 4.06% | 2,020,057 | 13.59M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 3.69% | 1,832,196 | 12.33M | Sep 29, 2024 |
| Millennium Management Llc | 2.61% | 1,296,590 | 8.73M | Sep 29, 2024 |
| State Street Corporation | 2.51% | 1,245,677 | 8.38M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Pacer Small Cap U.S. Cash Cows 100 ETF | 4.77% | 2,373,503 | 15.97M | Jul 30, 2024 |
| Vanguard Total Stock Market Index Fund | 3.28% | 1,631,724 | 10.98M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.69% | 1,335,112 | 8.99M | Oct 30, 2024 |
| Federated Hermes MDT Small Cap Core Fund | 2.35% | 1,166,788 | 7.85M | Jul 30, 2024 |
| Vanguard Extended Market Index Fund | 1.63% | 809,977 | 5.45M | Sep 29, 2024 |
| Schwab Strategic Tr-Schwab Fundamental U.S. Small Company Index ETF | 1.29% | 641,656 | 4.32M | Aug 30, 2024 |